A small proportion of patients infected with Helicobacter pylori or using non-steroidal anti-inflammatory drugs (NSAIDs
Introduction
Helicobacter pylori and non-steroidal anti-inflammatory drugs (NSAIDs) are the two major etiologic factors involved in peptic ulcer disease. Available evidence suggests that more than 50% of the world population is colonised by H. pylori. Chronic gastritis develops in virtually all infected individuals, but only a small proportion of persons will experience clinically significant diseases, including peptic ulcer disease, gastric carcinoma or gastric mucosa-associated lymphoid tissue (MALT) lymphoma. 1 Therefore, it seems reasonable to assume that host factors could also be important determinants of the clinical outcome of H. pylori infections, as evidenced by a proband-wise concordance rate of 23.6% in monozygotic twins and 14.8% in dizygotic twins in a Finnish twin study. 2 Among these host factors, the intensity or nature of the immune response to H. pylori might vary between individuals. Vigorous immune responses might lead to either autoimmune tissue injury or injury due to severe cellular inflammatory response, but weak responses might favour uncontrolled organism growth. 3 Cytokines, produced by several cell types, are key mediators in the genesis of inflammation and tissue repair. The levels of proinflammatory cytokines, including TNF are increased in the gastric mucosa of patients with H. pylori infection. [4] [5] [6] [7] Moreover, it has been suggested that H. pylori infection associated with a predominant Th1 response by the host may lead to peptic ulcer through modulation of gastric secretion. This is in part due to TNF, which is able to induce functional alteration of gastric cells. 8, 9 Shibata et al 10 have shown that in H. pylori-positive individuals a variable increased production of TNF correlated with the inflammation and an accompanied rise in the levels of soluble TNF receptors. TNF is also involved in NSAIDinduced gastric damage and agents that regulate TNF synthesis affect indomethacin-induced gastric damage. 11, 12 Early studies described stable inter-individual differences in cytokine production that might be genetically determined. 13, 14 TNF secretory responses were shown to be associated with certain HLA-DR haplotypes. 15 NcoI and AspHI restriction fragment length polymorphisms, 16, 17 in the first intron of the LTA gene, and two polymorphisms at positions −238 and −308 in the promoter region of the TNF gene have been described. 18, 19 We have previously shown the existence of only five haplotypes (TNF-C, -E, -H, -I, and -P) (Figure 1 ) encompassing these four bi-allelic polymorphisms in the Dutch population. 20, 21 Variations at these positions are important in the regulation of TNF and LT␣ production. Bouma et al 22 have shown that individuals carrying the TNF-I haplotype produce significantly less LT␣ when compared to those who lack this haplotype. Concerning TNF␣ secretion, carriers of the TNF-E haplotype produce significantly higher amounts of TNF␣ than individuals without this haplotype. In addition, individuals carrying the TNF-C haplotype produce the lowest amounts of TNF␣. Interestingly, TNF-C and TNF-E haplotypes differ only at position −308 in the promoter of the TNFA gene demonstrating that TNFA−308 polymorphism has direct effects on TNFA gene regulation and may be responsible for the association of TNFA−308 allele 2 with high TNF␣ secretion. 23 Other studies confirm the association of TNFA−308 allele 2/LTANcoI allele 1 haplotype (which is included in the TNF-E haplotype) with a high TNF␣ production phenotype and suggest the idea that these polymorphisms should be analysed as haplotypes rather than as individual alleles. [24] [25] [26] The localisation of the tandemly arranged TNF and LTA genes, encoding respectively TNF and LT␣ in the MHC class III region at the short arm of chromosome 6 (6p21.3) has prompted interest in the study of their contribution to diverse inflammatory processes. The objective of this study was to assess these four bi-allelic polymorphisms in the TNF and LTA genes and the haplotypes they constitute in patients with peptic ulcer disease and its implication in the outcome of patients with peptic ulcer disease associated with H. pylori infection. 
Results

Demographic and clinical characteristics of patients and controls
The clinical characteristics of gastric and duodenal ulcer patients and controls are shown in Table 1 . As expected, H. pylori infection was present in most patients with peptic ulceration and was more frequent in both duodenal (95.9%) and gastric ulcer patients (81.1%) than in controls (73.3%). H. pylori infection was equally distributed among males and females in all patient groups and controls and between ulcer patients younger and older than 50 years of age (data not shown). Only a small proportion of these ulcer patients were H. pylori-negative and NSAID-positive (6%; two duodenal ulcer and eight gastric ulcer) and an even smaller proportion were negative for both factors (2.4%; three duodenal ulcer and one gastric ulcer).
TNF, LTA alleles and TNF haplotypes Genotype and allele frequencies of the four polymorphisms studied are reported in Table 2 . No significant differences were found between patients and controls, but there was a different distribution of the TNF−308 and LTANcoI genotypes among duodenal and gastric ulcer patients. Genotype TNF−308 1.1 was more frequent in patients with gastric ulcer (91.8%) than in patients with duodenal ulcer (72.1%), whereas the genotype LTANcoI 2.2 was also more frequent in patients with gastric ulcer (64%) than in patients with duodenal ulcer (46.5%). Genotypes, alleles and haplotypes were equally distributed in males and females. Carriers of haplotype TNF-I were more frequent in patients with gastric ulcer (49%) than in controls (28%), and carriers of haplotype TNF-E were more frequent in duodenal ulcer than in gastric ulcer patients (Table 3) . When analysed by different clinical characteristics such as H. pylori status and NSAID use at the time of the bleeding episode, the tendency for differences found in genotype TNF−308 1.1, genotype LTANcoI 2.2, haplotype TNF-I and haplotype TNF-E were maintained, although no statistically significant differences were found (data not shown).
Of the environmental and genetic factors evaluated in this study, H. pylori infection, the presence of a positive family history, haplotype TNF-I and NSAID use at the time of the bleeding episode were identified as independently associated with peptic ulceration. Logistic regression analysis identified carriage of haplotype TNF-I as the only genetic risk factor for both gastric ulcer (OR = 4.4; 95% CI = 1.1-17.2) and duodenal ulcer (OR = 2.4; 95% CI = 1.1-5.5) in patients with H. pylori infection (Table 4) .
Discussion
H. pylori infection and NSAIDs are critical factors for the initiation of gastroduodenal mucosal damage. There is, however, a wide agreement that host genetic factors must at least partly determine the response to these agents and the final clinical outcome. 27 In this study H. pylori infection, TNF and LTA genes and NSAID use were independent risk factors associated with peptic ulceration. The frequency of H. pylori infections among patients and controls was within the expected range for a Mediterranean country like Spain, but the frequency of history Carrier: carrier of at least one copy of the respective haplotype. *P Ͻ 0.05 vs control, **P Ͻ 0.01 vs gastric ulcer. Age, sex, other TNF haplotypes, NSAID use at time of the bleeding episode and interaction terms were included in the model. NS, non-significant.
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of NSAID use (in most cases short term use) was probably biased by the type of patients studied, which included a high proportion of patients with a history of bleeding ulcers. This, however, did not affect the main conclusion of the study, since the analysis adjusted by confounding factors confirmed that both environmental and genetic factors affected the peptic ulcer outcome. Current knowledge of the genetic factors contributing to peptic ulcer risk is poor, and few markers have been studied. Most of the studies, since the early 1950s, have been directed to the ABO blood groups and later to the Lewis antigens and HLA genotypes. [28] [29] [30] [31] Although some progress has been made regarding the implications of Lewis antigens in the gastric mucosa as factors influencing H. pylori attachment to the epithelium, the association of peptic ulcers and blood group antigens remains uncertain. 29 Similarly, the association of HLA antigens with peptic ulceration is weak and not confirmed in all studies. Only the study performed by Azuma et al 32 in a Japanese population of duodenal ulcer patients reports the association of specific HLA-DQA alleles with duodenal ulcer disease. They found a significant increase of the HLA-DQA1*0102 allele frequency in H. pylori-negative controls compared to H. pylori-positive duodenal ulcer patients. In addition, the frequency of the HLA-DQA1*0301 allele was significantly lower in H. pylorinegative controls compared to H. pylori-positive duodenal ulcer patients. In another study performed by the same authors, they reported the protective role of the HLA-DQA1*0102 allele in the evolution of H. pylori infection in the development of gastric atrophy and gastric cancer. 33 Beales et al 34 have shown that the HLA-DQ5 allele was significantly higher in patients with H. pylori infection and evidence of atrophy or metaplasia than in those without atrophy or metaplasia, in both the infected and non-infected group. We have analysed the frequency of the HLA-DQA1*0102 and -DQA1*0301 alleles in our control subjects and patients with peptic ulcer trying to assess their influence on peptic ulcer susceptibility. 35 Although the distribution of the HLA-DQA1*0301 allele was more frequent in patients with gastric ulcer than in those with duodenal ulcer we did not find any significant differences in HLA-DQA1*0102 and -DQA1*0301 allele frequencies between peptic ulcer patients and controls. Further studies need to be performed in our control and peptic ulcer populations in order to investigate the role of other HLA genes in the susceptibility to gastric and duodenal ulcer. All these results suggest that other genes in linkage disequilibrium with the HLA class II genes on chromosome 6 may be important in disease susceptibility or in regulating the severity of the inflammation. From this point of view, TNF gene polymorphisms are good candidates to study, since genes identified in the TNF-LT region are important in the definition of ancestral MHC haplotypes and about 70% of these are ancestral haplotypes or recombinants of no more than two of them. [36] [37] [38] In addition, TNF is a cytokine involved in both H. pylori and NSAID-induced gastroduodenal damage 10, 11 ulcer repair 39 and other mechanisms that regulate gastric function. 40, 41 In this study we have found that polymorphisms in the TNF and LTA genes are associated with peptic ulcer. One-fourth of the duodenal ulcer population studied were carriers of the haplotype TNF-E (27%) whereas only 8% of patients with gastric ulcer carried this haplotype. This is a logical consequence of the higher frequency of the TNF−308 allele 2 found in duodenal ulcer patients, since only the haplotype TNF-E encompasses this allele (see Figure 1) . The LTANcoI genotype 2.2 was found more frequent in patients with gastric ulcer than patients with duodenal ulcer. More significantly, however, is the finding of a strong positive association of peptic ulceration with haplotype TNF-I, which was an independent factor associated with both duodenal and gastric ulceration (Table 4) in H. pylori-infected patients. Half the patients studied with gastric ulcer were carriers of this haplotype. Carriers of haplotype TNF-I produced less LT␣ than individuals who lack this haplotype. 22 The differences in frequency of distinct haplotypes in duodenal and gastric ulcers support previous family and epidemiological data 2, 42, 43 suggesting a difference in the immunogenetic background for suffering from gastric or duodenal ulcers. In addition, the finding that none of the four gene polymorphisms studied is independently associated with either gastric ulcer or duodenal ulcer, but a positive association exists between gastric ulcer and haplotype TNF-I, suggests the presence of a gene, or a set of genes on this extended risk haplotype to be associated to gastric ulcer disease.
With the exception of the data presented in our manuscript no other data exist in Spain with relation to the frequency and distribution of the TNF haplotypes mentioned above. Some studies performed in central and other northern areas in Spain report similar allele frequencies of TNFA−308, TNFA−238, and LTA NcoI polymorphisms to those found in our control population. [44] [45] [46] However, in the absence of other studies confirmatory analysis in other populations in Spain should be carried out in order to determine the frequency and distribution of the TNF haplotypes.
In summary, this study provides new data confirming the importance of genetic factors in the pathogenesis of gastric and duodenal ulcer. Further studies are necessary in order to assess the increased production of TNF upon stimulation with H. pylori in individuals with these haplotypes.
Patients and methods
Patients
We prospectively studied 180 consecutive patients with endoscopically diagnosed peptic ulcer disease attending the University Hospital Zaragoza (Spain), and 102 unrelated ethnically-matched healthy controls without active or past peptic ulcer history. All patients and controls were white Caucasians from the region of Aragó n in the northeast of Spain. One hundred and thirty patients had a duodenal ulcer and 50 had a gastric ulcer. One hundred and twenty-one patients had a history of bleeding ulcers (77 duodenal ulcer and 44 gastric ulcer). The diagnosis of peptic ulcer was based on endoscopic findings. The study protocol was approved by the Institutional Review Board of the University Hospital of Zaragoza. All patients and controls gave informed consent to the study, which was conducted in accordance with the Ethical and Clinical Assays Committee.
H. Pylori diagnosis
In patients, the presence of H. pylori infection was determined by both urease test (CLO-test; Delta West, Canning Vale, Bentley, Australia) and histological examination from biopsies taken at the antrum and corpus of the stomach during the endoscopic procedure. In addition, 13 C-urea breath test (Isomed, Madrid, Spain) was performed, according to standard procedures, in all patients who were negative by invasive methods, since in some cases these patients were on proton pump inhibitor treatment at the time of the endoscopic procedure. In controls, the presence of H. pylori infection was diagnosed by both 13 C-urea breath test and, serology using a commercial IgG ELISA kit (Plate Helicobacter IgG, Boehringer Mannheim UK, East Sussex, UK). This test has a sensitivity of 94% and specificity of 85% for H. pylori infection when the titre is Ͼ1.2.
NSAIDs use
The use of NSAIDs at the time of the endoscopic diagnosis of the peptic ulcer was determined by structured data collection. A patient was considered positive if the drug had been taken within the week prior to the endoscopic diagnosis of peptic ulcer disease.
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TNF and LTA gene polymorphisms Genomic DNA was extracted from EDTA anti-coagulated peripheral blood samples according to a standard proteinase K digestion and a phenol/chloroform extraction method. We studied two bi-allelic polymorphisms in the TNF gene and two in the LTA gene. Alleles of the single nucleotide polymorphisms at positions −238 and −308 in the promoter region of the TNF gene were detected by a PCR single-stranded conformation polymorphism method as detailed elsewhere. 21 PCR amplification with primers located in the 5Ј untranslated region and the third intron of the LTA gene resulted in a 740-bp fragment that was either cut in 555-bp and 185-bp fragments (LTANcoI allele1) or remained intact (LTANcoI allele 2) following incubation with the restriction endonuclease NcoI (Gibco/BRL, Life Technologies, Rockville, MD, USA). 16 For typing the AspHI RFLP the 740-bp PCR fragment was digested with the isoschizomer BsiHKAI (New England Biolabs, Beverly, MA, USA). 17 This resulted in 425-bp and 315-bp fragments (LTAAspHI allele 1) or the undigested fragment (LTAAspHI allele 2). The fragments obtained after digestion were separated by electrophoresis in a 2% agarose gel.
TNF haplotypes
We have previously shown that the alleles of the four gene polymorphisms studied at positions −238 and −308 in the promoter region of the TNF gene and in the first intron of the LTA gene (NcoI RFLP and the AspHI RFLP) are arranged in only five haplotypes. 20 Evidence for the existence of a limited number of haplotypes, denoted haplotype TNF-C, -E, -I, and -P came from typing the four gene polymorphisms in a panel of 22 B-lymphoblastoid cell lines homozygous for the MHC. 48 The results of typing 100 Dutch Caucasian healthy control individuals and 300 patients with different diseases has strengthened these findings and provided evidence for the existence of the rare haplotype TNF-H. 21 A current family study performed by our group in Dutch celiac patients and the analysis of TNF polymorphisms in controls and patients from Sweden and Hungary revealed the existence of these haplotypes in other European populations (data not published). Recent studies have confirmed that these five
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TNF haplotypes are present in 98.5% of Caucasoid controls from the UK. 36 Fanning et al 49 determined a total of 11 TNF-LTA haplotypes after analysing three biallelic polymorphisms in the TNF gene (−308, −238, +488) and three in the LTA gene (+249, +365, +720) in a case-control study also performed in the UK. 49 
Statistical analysis
Statistical analysis was performed by chi-square test with Yates' continuity correction for the comparison of phenotype frequencies between different groups of patients and healthy controls. The strength of the association between the TNF and the LTA alleles and the TNF haplotypes in each of the patient groups and controls was first estimated by Fisher's exact test (2 × 2 contingency tables). A two-sided P-value Ͻ0.05 was considered statistically significant. Hardy-Weinberg equilibrium was tested in the control samples by a 2 test with one degree of freedom (df).
A small number of patients and controls were not tested for all the four polymorphisms studied (two patients and one control were not typed for TNF gene and three patients and one control were not typed for LTA gene). In addition, in 16 of 282 patients and controls there was no complete information regarding the presence or absence of family history, but the pattern and extent of missing data in these patients did not follow any pattern and were completely at random. In the bivariate analysis all available data were used for each type of comparison. However, in order to quantify the actual influence of both genetic and environmental factors on the outcome of peptic ulceration, and after adjusting for confounding factors, unconditional logistic regression analysis was carried out (BMDP Dynamic v 7.0 program; BMDP Statistical Software) using those patients and controls who had all the information available. Starting with age and sex variables, the model was constructed with a step-wise forward conditional method. A variable was entered in the model if the significance level of its coefficient was less than 0.05 and was removed if it was greater than 0.10. Categorical variables included in the models were codified as dummy variables. Interaction terms were also tested in the different models.
